Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice.

scientific article published on 21 September 2006

Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.ATV.0000246774.02426.71
P698PubMed publication ID16990555

P50authorAldons Jake LusisQ60642067
P2093author name stringJanusz H S Kabarowski
Brian W Parks
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectaortic atherosclerosisQ18553821
lipoproteinQ28350
knockout mouseQ1364740
atherosclerosisQ12252367
P304page(s)2703-2709
P577publication date2006-09-21
P1433published inArteriosclerosis, Thrombosis, and Vascular BiologyQ4797542
P1476titleLoss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice.
P478volume26

Reverse relations

cites work (P2860)
Q37186078ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells
Q34546651Autoimmune‐mediated reduction of high‐density lipoprotein–cholesterol and paraoxonase 1 activity in systemic lupus erythematosus–prone gld mice
Q36709598CD36, but not G2A, modulates efferocytosis, inflammation, and fibrosis following bleomycin-induced lung injury
Q41880018Deletion of the G2A receptor fails to attenuate experimental autoimmune encephalomyelitis
Q90364624G2A Protects Mice against Sepsis by Modulating Kupffer Cell Activation: Cooperativity with Adenosine Receptor 2b
Q37339837G2A and LPC: regulatory functions in immunity
Q24643942G2A deficiency in mice promotes macrophage activation and atherosclerosis
Q35975437Genetic basis of atherosclerosis: insights from mice and humans
Q36459127High-resolution association mapping of atherosclerosis loci in mice
Q38946503Hydroxyoctadecadienoic acids regulate apoptosis in human THP-1 cells in a PPARγ-dependent manner.
Q56987439Identification of the first surrogate agonists for the G protein-coupled receptor GPR132
Q93052009Lysophosphatidylcholine Induces NLRP3 Inflammasome-Mediated Foam Cell Formation and Pyroptosis in Human Monocytes and Endothelial Cells
Q38742072Lysophospholipids and Their Receptors Serve as Conditional DAMPs and DAMP Receptors in Tissue Oxidative and Inflammatory Injury
Q38371352Macrophage phenotypic plasticity in atherosclerosis: The associated features and the peculiarities of the expression of inflammatory genes
Q38125279Molecular biology of atherosclerosis
Q30413906Phenotypic modulation of macrophages in response to plaque lipids
Q43289695Phospholipase A2 inhibitors in the treatment of atherosclerosis: a new approach moves forward in the clinic
Q36229028Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction
Q30435755The G protein-coupled receptor G2A: involvement in hepatic lipid metabolism and gallstone formation in mice

Search more.